Schwab Andrew J. sold SKYE
September 22, 2026 · Form 4 insider transaction
Schwab Andrew J. sold 1,088 shares of Skye Bioscience, Inc. at $1.65 per share, a transaction worth $1.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,088
Price
$1.65
Total value
$1.8K
InsiderSchwab Andrew J.
RoleDirector, 10% owner
CompanySkye Bioscience, Inc. (SKYE)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2026
Filing dateSeptember 24, 2026
Shares owned after4,528
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.